Jonathan R Roth

Dr. Jonathan R Roth

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2020 in eLife
Verified
Journal Article
Open access
YVYuliya Voskobiynyk
Yuliya Voskobiynyk
JRJonathan R Roth
Jonathan R Roth
JCJ Nicholas Cochran
J Nicholas Cochran
TRTravis Rush
Travis Rush
NCNancy Carullo
Nancy Carullo
ERErik D Roberson
Erik D Roberson
Genome-wide association studies identified the BIN1 locus as a leading modulator of genetic risk in Alzheimer’s disease (AD). One limitation in understanding BIN1’s contribution to AD is its unknown function in the brain. AD-associated BIN1 variants are generally noncoding and likely change expression. Here, we determined the effects of increasing expression of the major neuronal isoform of human BIN1 in cultured rat hippocampal neurons. Higher BIN1 induced network hyperexcitability on multielectrode arrays, increased frequency of synaptic transmission, and elevated calcium transients, indicating that increasing BIN1 drives greater neuronal activity. In exploring the mechanism of these effects on neuronal physiology, we found that BIN1 interacted with L-type voltage-gated calcium channels (LVGCCs) and that BIN1–LVGCC interactions were modulated by Tau in rat hippocampal neurons and mouse brain. Finally, Tau reduction prevented BIN1-induced network hyperexcitability. These data shed light on BIN1’s neuronal function and suggest that it may contribute to Tau-dependent hyperexcitability in AD.

9 January 2023 in Obesity
Verified
Journal Article
Closed access
JRJonathan R Roth
Jonathan R Roth
SVShweta Varshney
Shweta Varshney
RMRuan Carlos Macedo de Moraes
Ruan Carlos Macedo de Moraes
GMGirish Melkani
Girish Melkani

25 October 2024 in Genes
Verified
Journal Article
Open access
PDF file
Ruan C M MoraesRuan C M Moraes
Ruan C M Moraes
JRJonathan R Roth
Jonathan R Roth
HMHailey Mao
Hailey Mao
SCSavannah Crawley
Savannah Crawley
BXBrittney P. Xu
Brittney P. Xu
GMGirish Melkani
Girish Melkani
Background: Apolipoprotein E (ApoE) is the leading genetic risk factor for late-onset Alzheimer’s disease (AD), which is the leading cause of dementia worldwide. Most people have two ApoE-ε3 (ApoE3) alleles, while ApoE-ε2 (ApoE2) is protective from AD, and ApoE-ε4 (ApoE4) confers AD risk. How these alleles modulate AD risk is not clearly defined, and ApoE’s role in lipid metabolism is also not fully known. Lipid droplets increase in AD. However, how ApoE contributes to lipid accumulation in the brain remains unknown. Methods: Here, we use Drosophila to study the effects of ApoE alleles on lipid accumulation in the brain and muscle in a cell-autonomous and non-cell-autonomous manner. Results: We report that pan-neuronal expression of each ApoE allele induces lipid accumulation specifically in the brain, but not in the muscle. However, this was not the case when expressed with muscle-specific drivers. ApoE2- and ApoE3-induced lipid accumulation is dependent on the expression of Dgat2, a key regulator of triacylglycerol production, while ApoE4 still induces lipid accumulation even with knock-down of Dgat2. Additionally, we find that implementation of time-restricted feeding (TRF), a dietary intervention in which food access only occurs in the active period (day), prevents ApoE-induced lipid accumulation in the brain of flies and modulates lipid metabolism genes. Conclusions: Altogether, our results demonstrate that ApoE induces lipid accumulation in the brain, that ApoE4 is unique in causing lipid accumulation independent of Dgat2, and that TRF prevents ApoE-induced lipid accumulation. These results support the idea that lipid metabolism is critical in AD, and that TRF could be a promising therapeutic approach to prevent ApoE-associated dysfunction in lipid metabolism.

7 February 2025 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
JWJohn Watson
John Watson
JRJonathan R Roth
Jonathan R Roth
GMGirish Melkani
Girish Melkani
Immunostaining Drosophila melanogaster brains is essential for exploring the mechanisms behind complex behaviors, neural circuits, and protein expression patterns. Traditional methods often involve challenges such as performing complex dissection, maintaining tissue integrity, and visualizing specific expression patterns during high-resolution imaging. We present an optimized protocol that combines cryosectioning with fluorescence staining and immunostaining. This method improves tissue preservation and signal clarity and reduces the need for laborious dissection for Drosophila brain imaging. The method entails rapid dissection, optimal fixation, cryoprotection, and cryosectioning, followed by fluorescent staining and immunostaining. The protocol significantly reduces tissue damage, enhances antibody penetration, and yields sharp, well-defined images. We demonstrate the effectiveness of this approach by visualizing specific neural populations and synaptic proteins with high fidelity. This versatile method allows for the analysis of various protein markers in the adult brain across multiple z-planes and can be adapted for other tissues and model organisms. The protocol provides a reliable and efficient tool for researchers conducting high-quality immunohistochemistry in Drosophila neurobiology studies. This method's detailed visualization facilitates comprehensive analysis of neuroanatomy, pathology, and protein localization, making it particularly valuable for neuroscience research.

31 October 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
TRTravis Rush
Travis Rush
JRJonathan R Roth
Jonathan R Roth
STSamantha J. Thompson
Samantha J. Thompson
AAAdam R. Aldaher
Adam R. Aldaher
JCJ. Nicholas Cochran
J. Nicholas Cochran
ERErik D. Roberson
Erik D. Roberson
The microtubule-associated protein Tau is strongly implicated in Alzheimer’s disease (AD) and aggregates into neurofibrillary tangles in AD. Genetic reduction of Tau is protective in several animal models of AD and cell culture models of amyloid-β (Aβ) toxicity, making it an exciting therapeutic target for treating AD. A variety of evidence indicates that Tau’s interactions with Fyn kinase and other SH3 domain–containing proteins, which bind to PxxP motifs in Tau’s proline-rich domain, may contribute to AD deficits and Aβ toxicity. Thus, we sought to determine if inhibiting Tau-SH3 interactions ameliorates Aβ toxicity. We developed a peptide inhibitor of Tau-SH3 interactions and a proximity ligation assay (PLA)-based target engagement assay. Then, we used membrane trafficking and neurite degeneration assays to determine if inhibiting Tau-SH3 interactions ameliorated Aβ oligomer (Aβo)-induced toxicity in primary hippocampal neurons from rats. We verified that Tau reduction ameliorated Aβo toxicity in neurons. Using PLA, we identified a peptide inhibitor that reduced Tau-SH3 interactions in HEK-293 cells and primary neurons. This peptide reduced Tau phosphorylation by Fyn without affecting Fyn’s kinase activity state. In primary neurons, endogenous Tau-Fyn interaction was present primarily in neurites and was reduced by the peptide inhibitor, from which we inferred target engagement. Reducing Tau-SH3 interactions in neurons ameliorated Aβo toxicity by multiple outcome measures, namely Aβo-induced membrane trafficking abnormalities and neurite degeneration. Our results indicate that Tau-SH3 interactions are critical for Aβo toxicity and that inhibiting them is a promising therapeutic target for AD.

25 March 2026 in Journal of Neuroscience
Verified
Journal Article
Open access
ACAnastasiia E. Caangay
Anastasiia E. Caangay
DGDevon K. Grey
Devon K. Grey
CNCatherine E. Newman
Catherine E. Newman
CECameryn T. Eickstead
Cameryn T. Eickstead
TWTeel E. Walters
Teel E. Walters
KVKristina M. Visscher
Kristina M. Visscher
Science communication plays an essential role in bridging the gap between researchers and the general public. Now, more than ever, it is essential for neuroscientists to interact with their communities to increase understanding of basic neuroscience concepts and enhance trust in academic scientists as members of the community. However, it can be difficult, as scientists, to develop and maintain effective lines of communication with the public. To address this, at the University of Alabama at Birmingham, we have been organizing public outreach events aimed to educate the public about various aspects of neuroscience. The goal of this article is to share our strategy for expanding our successful once-per-year “Brain Awareness Week” event to a year-round “Neuroscience for All” program and to provide practical materials and a dedicated, interactive GitHub-based platform for discussion of personal experiences and extensions and improvements to materials. We hope that the resources and examples we outline will facilitate other institutions to easily expand existing programs or create new ones from scratch and that our online forum will facilitate broader discussion and improvement of neuroscience outreach initiatives across institutions.